HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

miltefosine

hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
Also Known As:
Baxter Oncology brand of miltefosine; Baxter brand of miltefosine; D 18506; D-18506; D18506; HDPC; Miltex; Prasfarma brand of miltefosine; hexadecylphosphocholine; n-hexadecylphosphorylcholine; Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt
Networked: 456 relevant articles (69 outcomes, 77 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sundar, Shyam: 23 articles (01/2015 - 11/2002)
2. Dorlo, Thomas P C: 12 articles (12/2015 - 08/2008)
3. Gupta, Suman: 10 articles (10/2015 - 04/2005)
4. Das, Pradeep: 9 articles (02/2016 - 03/2009)
5. Sindermann, Herbert: 9 articles (08/2007 - 11/2002)
6. Pandey, Krishna: 8 articles (02/2016 - 08/2007)
7. Beijnen, Jos H: 8 articles (07/2014 - 08/2008)
8. Ramesh, V: 7 articles (10/2015 - 01/2008)
9. Rivas, Luis: 7 articles (06/2015 - 10/2006)
10. Dujardin, Jean-Claude: 7 articles (07/2014 - 08/2012)

Related Diseases

1. Visceral Leishmaniasis (Kala Azar)
2. Leishmaniasis
3. Cutaneous Leishmaniasis
4. Infection
5. Ulcer

Related Drugs and Biologics

1. miltefosine
2. Paromomycin (Paromomycin Sulfate)
3. Amphotericin B (Amphotericin)
4. kutkin
5. liposomal amphotericin B
6. edelfosine
7. Antineoplastic Agents (Antineoplastics)
8. Antimony Sodium Gluconate (Sodium, Stibogluconate)
9. Antimony
10. Phospholipids

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)
3. Oral Administration
4. Radiotherapy
5. Injections